Cooperative Agreement NU58DP007694
- Federal Project Grant Award Summary Boston Children's Hospital received a $705,715 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective February 1, 2026, with a completion date of December 31, 2030. The award funds a multiomic investigation into sudden unexplained pediatric deaths (SUDP), including Sudden Infant Death Syndrome (SIDS)...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a Project Grant award of $148,880 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award, issued on May 19, 2025, with completion targeted for May 18, 2028, supports research investigating the role of the GSX2 transcription factor gene in hindbrain neurogenesis and its implications for...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Missouri System a $2.106 million Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the neurobiological mechanisms underlying Sudden Infant Death Syndrome (SIDS). The research, which commenced May 15, 2025, and extends through March 31, 2029, examines a novel serotonergic brainstem-cerebellar circuit hypothesis positing that reduced serotonin...
- Cooperative Agreement Summary Seattle Children's Research Institute received a $149,418 Cooperative Agreement award dated September 30, 2025, from the Center for State, Tribal, Local, and Territorial Support under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) to evaluate and strengthen Special Olympics' approach to sexual violence prevention. The three-year project, with an ultimate completion date of September 29, 2028, will focus on assessing...
- Federal Grant Award Summary The University of Wisconsin System received a $2.12 million Project Grant from the Health Resources and Services Administration Maternal and Child Health Bureau under the Autism Collaboration, Accountability, Research, Education, and Support (Autism CARES) Act Program (CFDA 93.877), awarded September 1, 2025, with completion targeted for August 31, 2028. The Autism Research Consortium-Systems of Care initiative will advance systems-level implementation of...
- Federal Cooperative Agreement Summary Seattle Children's Hospital, doing business as Seattle Children's Research Institute, received a $4.6 million Cooperative Agreement from the National Institute of Neurological Disorders and Stroke under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 19, 2025, with completion targeted for July 31, 2030. This award funds the development of a precision health model for pediatric chronic primary pain that leverages the PEDSnet national...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $116,685 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025, through August 17, 2027. This award supports a two-phase research initiative examining cancer survivorship needs and reintegration outcomes for children with Down Syndrome (DS) who are in remission from...
- Federal Project Grant Award Summary Seattle Children's Hospital (doing business as Seattle Children's Research Institute) received a $754,584 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025 through May 31, 2030. The award funds a randomized controlled trial evaluating the effectiveness of the Family Safety Check-In, an interactive...
- Federal Grant Award Summary Wayne State University received a $423,500 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective August 1, 2025 through July 31, 2027. The research project, titled "Placenta-Specific Maternal Plasma Proteomic Biomarkers of Fetal Death," is led by Principal Investigator A.L. Tarca and will be conducted in Detroit, Michigan....
- Federal Project Grant Award Summary Children's Hospital Los Angeles received a $661,575 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective August 1, 2025, with a completion date of May 31, 2030. Under this five-year research initiative, Dr. Jonathan D. Santoro and his multidisciplinary team will conduct the first comprehensive neurodiagnostic and multi-omics...
WISCONSIN SUID PROJECT - DESCRIPTIVE TITLE: STATEWIDE SUID SURVEILLANCE AND CATEGORIZATION IN WISCONSIN AND IMPROVEMENT OF DEATH SCENE INVESTIGATIONS. SUDDEN AND UNEXPECTED INFANT, CHILD, AND ADOLESCENT DEATHS ARE AN INDICATION OF A COMMUNITY'S HEALTH AND SHOULD ELICIT A COLLECTIVE RESPONSE, INCLUDING EFFORTS TO UNDERSTAND THE CIRCUMSTANCES AND RISK FACTORS IN ORDER TO PREVENT FUTURE DEATHS. CHILDREN'S HEALTH ALLIANCE OF WISCONSIN (THE ALLIANCE) HAS BEEN FUNDED SINCE 2012 FOR SUDDEN UNEXPECTED INFANT DEATH (SUID) SURVEILLANCE. DURING THIS TIME, OUR EXPERIENCE AND FINDINGS FROM SUID HAVE BEEN USED TO DRIVE STATEWIDE SAFE SLEEP PREVENTION, DEATH SCENE INVESTIGATION (DSI) TRAININGS, AND COMMUNITY CONVERSATIONS ABOUT PREVENTABLE DEATHS. THE ALLIANCE IS ENTHUSIASTIC TO CONTINUE THIS IMPORTANT WORK TO FURTHER THE UNDERSTANDING OF RISK FACTORS AMONG WISCONSIN FAMILIES WITH THE LONG-TERM OUTCOMES OF REDUCING SUID INCIDENCE AND STANDARDIZING THE INVESTIGATION AND REPORTING OF THESE DEATHS. THE PURPOSE OF THE SUID CASE REGISTRY IS TO USE WISCONSIN'S EXISTING DEATH REVIEW SYSTEMS AND STRONG PARTNERSHIPS TO ESTABLISH SUID INCIDENCE THROUGH COMPLETE AND TIMELY CASE IDENTIFICATION, REVIEW, CATEGORIZATION AND DATA ENTRY. WISCONSIN WILL CONTINUE TO UTILIZE SUID SURVEILLANCE TO INFORM LOCAL AND STATE PREVENTION AND ULTIMATELY REDUCE SUDDEN AND UNEXPECTED INFANT DEATHS IN WISCONSIN. THE ALLIANCE WILL ACHIEVE THE FOLLOWING OUTCOMES BY THE END OF THE GRANT PERIOD: 1) INCREASE LOCAL AND STATE STAKEHOLDER ACCESS TO COMPLETE HIGH-QUALITY STATEWIDE SUID SURVEILLANCE, 2) DECREASE THE PERCENTAGE OF MISSING AND UNKNOWN PRIORITY VARIABLES FOR SUID STATEWIDE, THUS INCREASING THE COMPLETENESS AND QUALITY OF SUID SURVEILLANCE DATA, 3) DECREASE THE PERCENTAGE OF CASES THAT DO NOT MEET THE TIMELINESS STANDARDS FOR IDENTIFICATION, REVIEW, DATA ENTRY, AND QUALITY ASSURANCE, 4) INCREASE THE FEDERAL AND STATE STAKEHOLDER UNDERSTANDING OF SUID INCIDENCE, INCLUDING INCIDENCE BY SUID CATEGORY, 5) MAINTAIN CREATION OF WISCONSIN'S ANNUAL SUID REPORT TO INFORM LOCAL AND STATE PARTNERS IN THEIR PROGRAMMATIC AND POLICY PREVENTION EFFORTS, 6) INCREASE SUPPORT TO LOCAL PARTNERS, INCLUDING HEALTH DEPARTMENTS AND CDR TEAMS, TO UTILIZE AND DISSEMINATE SUID DATA IN THEIR PREVENTION EFFORTS AND IN COLLABORATIONS WITH THEIR STAKEHOLDERS, AND 7) INCREASE THE NUMBER OF COMPLETE SCENE INVESTIGATIONS AND DOLL RE-ENACTMENTS FOR SUID CASES BY EQUIPPING WISCONSIN AGENCIES WITH THE NECESSARY TOOLS AND SKILLS TO CONDUCT THOROUGH INVESTIGATIONS. THE ALLIANCE IS APPLYING FOR COMPONENT A TO PERFORM STATEWIDE SUID SURVEILLANCE AND CATEGORIZATION, AND COMPONENT C TO INCREASE THE AVAILABILITY OF DSI TRAININGS IN AREAS WITH THE HIGHEST NEED. THE ATTACHED LETTERS OF SUPPORT AND MEMORANDUMS OF UNDERSTANDING WILL DEMONSTRATE THE STRONG PARTNERSHIPS AND CAPACITY OF THE ALLIANCE TO CONDUCT SUID SURVEILLANCE AND MANAGE ANNUAL STATEWIDE DSI TRAININGS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $95.0k | 9/12/25 | ||
| Not listed | $95.0k | 8/1/24 | ||
| Not listed | $95.0k | 8/1/24 | ||
| Not listed | $95.0k | 8/1/24 | ||
| Not listed | $95.0k | 9/7/23 |